“…[25][26][27] However, the use of oligonucleotides labeled with organic dyes is limited by the high cost of synthesis of labeled DNA. 28,29 Moreover, the nanosecond lifetime of organic dyes is generally too short to allow their uorescence to be separated from the high background uorescence of samples and can result in false negatives, which greatly limits their drug screening applications. 30 Consequently, the problem of background uorescence is a major concern for the screening of small molecule inhibitors.…”